Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a tablet game help early Alzheimer's? new study tests App-Based training at home

NCT ID NCT07521865

Symptom relief Sponsor: University of Bern Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether older adults with mild cognitive impairment or early Alzheimer's can use a tablet-based brain-training app at home. 52 participants played 12 different games for 8 minutes each, daily for two weeks. The goal was to see if the app was easy to use and acceptable, not whether it improves memory.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
app-based cognitive training
What this could lead to
If successful, this could provide a convenient, at-home way to keep the mind active for people with early memory problems.
What could go wrong
This was a small, short-term feasibility study (52 participants, 2 weeks). It does not test whether the training actually improves memory or slows disease progression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

52 people

The number who actually took part.

Started

Jun 2023

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants will be recruited by newspaper adverts and flyers after public talks. It is also intended to recruit visitors from the day clinic as well as patients from the Interdisciplinary Memory Clinic (IDMC) Bern (https://www.memory-clinic-bern.ch/) and the Domicil care home group (www.domicilbern.ch).

Ages

70 to 95 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Participants and study partners fulfilling all the following inclusion criteria are eligible for the study: • Informed Consent as documented by signature Study partners: • Native or fluent German speaker Participants: * Are able to give their consent to participate in the study * Age between 70 and 95 years * Native or fluent German speaker * Normal or corrected to normal vision and hearing * Ability to visit the study location repeatedly * MoCA score \> 11 Exclusion Criteria: * Substance abuse * Severe neurological or psychiatric conditions (of note: patients with mild depressive symptoms not fulfilling the criteria for major depressive disorder will be recruited into the sample to better represent clinical reality)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alzheimer disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alzheimer disease App-based cognitive training Mild cognitive impairment Old age; dementia Remote cognitive training Serious games

Contacts and locations

Locations

  • University Hospital of Old Age Psychiatry and Psychotherapy Bern

    Bern, Canton of Bern, 3000, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.